SCIELE PHARMA, INC.

ADRENOMATE

Pharmaceutical preparations for use in prophylactic and therapeutic treatment of allergies and asthma; injectors and syringes containing epinephrine for the treatment of anaphylactic reactions, asthma attacks and allergic reactions;Hypodermic injectors;

ANAKIT

KIT CONTAINING MEDICATION FOR THE TREATMENT OF ANAPHYLACTIC SHOCK;KIT;KIT CONTAINING DISPOSABLE SYRINGES, SWABS AND TOURNIQUET;

AQELE

dermatologicals, namely, ectoparasite treatment preparations;

AQUELE

dermatologicals, namely, ectoparasite treatment preparations;

CLONIBID

Pharmaceutical products, in the form of an extended release oral dosage for the treatment of attention deficit hyperactivity disorders and other disorders characterized by excessive autonomic hyperactivity;

CLONIDAY

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

DEFEN

pharmaceutical products, namely, cough and cold remedy preparations;

DIBARO

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Hypertension and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

DUOCHOL

Pharmaceutical products for lowering lipids;

EFINLY

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

ENFOKIS

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

EPEZE

Pharmaceutical preparations for use in prophylactic and therapeutic treatment of allergies and asthma; auto-injectors and/or syringes containing epinephrine for the treatment or prevention of anaphylaxis and severe allergic reactions;Human Hypodermic injectors;

FENLIO

Pharmaceutical products, namely, lipid and triglyceride reducing agents;

GLERSA

Pharmaceutical preparations for use in the treatment of sailorrhea;

GLYCEVA

Pharmaceutical preparations for use in the treatment of sailorrhea;

INTELLIGENT CHOICE

Nutritional supplements;

JENLOGA

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Hypertension, Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

KAPSITI

Pharmaceutical Products, in the Form of an Extended Release Oral Dosage for the Treatment of Attention Deficit Hyperactivity Disorders and Other Disorders Characterized by Excessive Autonomic Hyperactivity;

MIJESTI

Pharmaceutical preparations, namely, local anesthetics used for temporary skin desensitization;

OSALVIA

Pharmaceutical preparations for use in the treatment of sialorrhea;

OZALVIA

Pharmaceutical preparations for use in the treatment of sialorrhea;

SALSTO

Pharmaceutical preparations for use in the treatment of sialorrhea;

SCIELE PHARMA SALES, INC.

The mark consists of the word SCIELE in blue, with a red line above the CI in SCIELE, and the words PHARMA SALES, INC. in red underneath.;SCIELE PHARMACEUTICAL SALES, INC.;The color(s) blue and red is/are claimed as a feature of the mark.;Wholesale distributorship services of pharmaceutical preparations, dietetic and nutritional substances for medical use and vitamins, namely, prescription pharmaceutical preparations for humans, namely, pain medications, antihistamines, decongestants, eardrops, liquid antitussives, cardiovascular and cardiology medications, preparations for treating metabolic disorders, anticholinergics, preparations for treating gasteroenterology conditions, preparations for treating neurology conditions including dementia, preparations for treating urinary tract infections, preparations for treating osteoporosis and preparations for treating women's health, prenatal vitamins and menstrual pain relief medications;PHARMA SALES, INC.;